23andMe And Nightingale Health Announced A Strategic Collaboration To Pilot Nightingale Health's Blood Metabolomics Panel With A Cohort Of 23andMe Members
Portfolio Pulse from Benzinga Newsdesk
23andMe and Nightingale Health have announced a strategic collaboration to pilot Nightingale Health's Blood Metabolomics Panel with a cohort of 23andMe members. Up to 5,000 23andMe+ Premium and Total Health members will receive free blood testing through Nightingale's Remote Health Check. The pilot aims to evaluate customer feedback on blood testing, at-home sample collection, and the utility of the data when combined with 23andMe's genetic products.

June 28, 2024 | 11:33 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
23andMe has announced a strategic collaboration with Nightingale Health to pilot a Blood Metabolomics Panel with up to 5,000 23andMe+ Premium and Total Health members. This initiative could enhance 23andMe's product offerings and customer engagement.
The collaboration with Nightingale Health to offer a Blood Metabolomics Panel could enhance 23andMe's product offerings and customer engagement. This initiative aligns with 23andMe's focus on personalized health and genetics, potentially driving customer interest and satisfaction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100